Table 5 Multivariable relative risks for subsequent primary meningiomas for survivors of CNS tumours and leukaemia.
Factor | Exposure | CNS tumour | Leukaemia |
|---|---|---|---|
RR (95% CI)a | RR (95% CI)a | ||
Cranial radiotherapyb | No | 1.0 (ref.) | 1.0 (ref.) |
Yes | 13.0 (6.7–25.4) | 5.4 (2.9–9.9) | |
Unknown | 6.7 (3.2–14.2) | 3.0 (1.5–6.1) | |
Pheterogeneity | <0.001 | <0.001 | |
Sexc | Males | 1.0 (ref.) | 1.0 (ref.) |
Females | 1.2 (1.0–1.5) | 1.4 (1.1–1.7) | |
Pheterogeneity | 0.13 | 0.01 | |
Era of childhood cancer diagnosisd | <1970 | 1.0 (ref.) | 1.0 (ref.) |
1970–1979 | 1.3 (1.0–1.7) | 9.2 (2.3–37.2) | |
1980–1989 | 1.6 (1.2–2.2) | 7.3 (1.8–29.8) | |
1990–2008 | 1.9 (1.2–3.0) | 2.1 (0.5–9.7) | |
Pheterogeneity | <0.001 | 0.001 | |
Age at childhood cancer diagnosise | 0–4 years | 1.0 (ref.) | 1.0 (ref.) |
5–9 years | 0.8 (0.6–1.1) | 0.9 (0.7–1.2) | |
10–14 years | 0.6 (0.5–0.9) | 0.5 (0.3–0.7) | |
15–20 years | 0.5 (0.4–0.7) | 0.2 (0.1–0.3) | |
Ptrend | <0.001 | <0.001 | |
Attained agef | <20 years | 1.0 (ref.) | 1.0 (ref.) |
20–29 years | 3.2 (2.1–4.9) | 7.6 (4.6–12.6) | |
30–39 years | 6.9 (4.4–10.8) | 22.3 (13.4–37.1) | |
40+ years | 10.2 (6.3–16.5) | 33.6 (18.9–59.8) | |
Ptrend | <0.001 | <0.001 |